SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,517 | +6.8% | 787,956 | +0.9% | 0.01% | +16.7% |
| Q2 2023 | $89,432 | -44.6% | 780,921 | -33.3% | 0.01% | -50.0% |
| Q1 2023 | $161,461 | +48.9% | 1,171,442 | +40.0% | 0.02% | +41.2% |
| Q4 2022 | $108,419 | -99.9% | 836,693 | -31.4% | 0.02% | -22.7% |
| Q3 2022 | $134,735,000 | +54.4% | 1,218,871 | +4.7% | 0.02% | +100.0% |
| Q2 2022 | $87,242,000 | -1.8% | 1,163,847 | +2.4% | 0.01% | +22.2% |
| Q1 2022 | $88,807,000 | +34.1% | 1,136,805 | +54.6% | 0.01% | +50.0% |
| Q4 2021 | $66,237,000 | +1.0% | 735,558 | +3.7% | 0.01% | 0.0% |
| Q3 2021 | $65,609,000 | +17.0% | 709,444 | -1.6% | 0.01% | +20.0% |
| Q2 2021 | $56,065,000 | +6.8% | 721,192 | +2.4% | 0.01% | 0.0% |
| Q1 2021 | $52,481,000 | -76.4% | 704,153 | -45.9% | 0.01% | -78.3% |
| Q4 2020 | $222,089,000 | +17.9% | 1,302,651 | -2.9% | 0.02% | +4.5% |
| Q3 2020 | $188,324,000 | -25.0% | 1,341,053 | -14.4% | 0.02% | -31.2% |
| Q2 2020 | $251,152,000 | +52.2% | 1,566,373 | -7.1% | 0.03% | +23.1% |
| Q1 2020 | $165,003,000 | -61.5% | 1,686,799 | -49.2% | 0.03% | -53.6% |
| Q4 2019 | $428,658,000 | +50.2% | 3,321,904 | -12.3% | 0.06% | +40.0% |
| Q3 2019 | $285,317,000 | -51.9% | 3,788,069 | -2.9% | 0.04% | -51.8% |
| Q2 2019 | $592,943,000 | +40.4% | 3,902,227 | +10.1% | 0.08% | +33.9% |
| Q1 2019 | $422,298,000 | -11.8% | 3,543,067 | -19.2% | 0.06% | -23.5% |
| Q4 2018 | $478,663,000 | -27.3% | 4,386,176 | +7.6% | 0.08% | -15.6% |
| Q3 2018 | $658,153,000 | +10.7% | 4,075,000 | -9.4% | 0.10% | +5.5% |
| Q2 2018 | $594,276,000 | +136.0% | 4,495,963 | +32.3% | 0.09% | +127.5% |
| Q1 2018 | $251,770,000 | +142.0% | 3,398,167 | +81.7% | 0.04% | +135.3% |
| Q4 2017 | $104,051,000 | +193.0% | 1,870,076 | +138.9% | 0.02% | +183.3% |
| Q3 2017 | $35,507,000 | +294.6% | 782,781 | +193.3% | 0.01% | +200.0% |
| Q2 2017 | $8,998,000 | -15.7% | 266,919 | -26.0% | 0.00% | 0.0% |
| Q1 2017 | $10,676,000 | +2.1% | 360,673 | -5.4% | 0.00% | 0.0% |
| Q4 2016 | $10,456,000 | -68.1% | 381,173 | -28.7% | 0.00% | -71.4% |
| Q3 2016 | $32,822,000 | +2822.7% | 534,468 | +807.9% | 0.01% | – |
| Q2 2016 | $1,123,000 | +9.0% | 58,868 | +11.6% | 0.00% | – |
| Q1 2016 | $1,030,000 | -15.7% | 52,768 | +66.6% | 0.00% | – |
| Q4 2015 | $1,222,000 | +20.6% | 31,668 | +0.4% | 0.00% | – |
| Q3 2015 | $1,013,000 | -14.1% | 31,548 | -18.6% | 0.00% | – |
| Q2 2015 | $1,179,000 | +234.0% | 38,748 | +46.0% | 0.00% | – |
| Q1 2015 | $353,000 | +72.2% | 26,548 | +87.6% | 0.00% | – |
| Q4 2014 | $205,000 | -31.4% | 14,148 | 0.0% | 0.00% | – |
| Q3 2014 | $299,000 | -29.0% | 14,148 | 0.0% | 0.00% | – |
| Q2 2014 | $421,000 | +50.4% | 14,148 | +21.5% | 0.00% | – |
| Q1 2014 | $280,000 | -65.2% | 11,648 | -31.7% | 0.00% | – |
| Q3 2013 | $805,000 | -98.8% | 17,048 | -99.0% | 0.00% | -100.0% |
| Q2 2013 | $66,530,000 | – | 1,748,496 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |